Sign In
Buy CRC
$62.20
+0.490 (+0.794%)
At Close: Jun 03, 2026
California Resources Corporation Announces Early Tender Results of Tender Offer for Certain of its 7.125% Senior Notes due 2026
08:15pm, Wednesday, 21'st Aug 2024
LONG BEACH, Calif.--(BUSINESS WIRE)--California Resources Corporation (NYSE: CRC) (the “Company”) today announced the early tender results in respect of the previously announced cash tender offer
California Resources Has 'Unique Exposure' To Meet Power Demand, Says Bullish Analyst On Heels Of Aera Merger
12:19pm, Wednesday, 21'st Aug 2024
Last month, California Resources Corp CRC completed its all-stock merger with Aera Energy, in a deal valued at $2.1 billion.
LONG BEACH, Calif.--(BUSINESS WIRE)--California Resources Corporation (NYSE: CRC) (the “Company”) previously announced the commencement of a cash tender offer (the “Tender Offer”) to purchase
LONG BEACH, Calif.--(BUSINESS WIRE)--California Resources Corporation (NYSE: CRC) (the “Company”) announced today the pricing of an upsized private offering of $300 million in aggregate principal
California Resources Corporation (CRC) Q2 2024 Earnings Call Transcript
06:47pm, Wednesday, 07'th Aug 2024
California Resources Corporation (NYSE:CRC ) Q2 2024 Earnings Conference Call August 7, 2024 1:00 PM ET Company Participants Joanna Park - Vice President, Investor Relations & Treasurer Francisco Leon
New Strong Sell Stocks for August 7th
07:05am, Wednesday, 07'th Aug 2024
IPGP, CRC and CUYTY have been added to the Zacks Rank #5 (Strong Sell) List on August 7, 2024.
California Resources Corporation (CRC) Misses Q2 Earnings and Revenue Estimates
07:57pm, Tuesday, 06'th Aug 2024
California Resources Corporation (CRC) came out with quarterly earnings of $0.60 per share, missing the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $0.53 per share a year
California Resources Reports Second Quarter 2024 Financial and Operating Results
04:31pm, Tuesday, 06'th Aug 2024
LONG BEACH, Calif.--(BUSINESS WIRE)-- #CCS--California Resources Corporation (NYSE: CRC) today reported financial and operating results for the second quarter of 2024. The Company plans to host a conf
Carbon TerraVault Provides Second Quarter 2024 Update
04:30pm, Tuesday, 06'th Aug 2024
LONG BEACH, Calif.--(BUSINESS WIRE)-- #CCS--Carbon TerraVault Holdings, LLC (CTV) today provided a second quarter 2024 update. California Resources Corporation (NYSE: CRC) conducts its carbon manageme
New Strong Sell Stocks for July 25th
07:25am, Thursday, 25'th Jul 2024
ALGT, CRC and MP have been added to the Zacks Rank #5 (Strong Sell) List on July 25, 2024.
Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer Screening
08:00am, Wednesday, 17'th Jul 2024
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded a total of $1.5 million to 28 organizations through its Fun
Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
03:01am, Tuesday, 09'th Jul 2024
On the basis of its positive clinical studies Mainz Biomed has now defined the final configuration including its novel mRNA biomarkers of the Next Generation Test to be used in pivotal registration st
California Resources Corporation Schedules Second Quarter 2024 Earnings Conference Call
09:00am, Friday, 05'th Jul 2024
LONG BEACH, Calif.--(BUSINESS WIRE)-- #2Q24Results--California Resources Corporation (NYSE: CRC) plans to release its second quarter 2024 financial results on Tuesday, August 6th after market close. T
California Resources (CRC) Concludes Merger With Aera Energy
09:40am, Tuesday, 02'nd Jul 2024
California Resources (CRC) expects capital expenditure to be in the $170-$210 million range for the combined entity and net daily production in the band of 140-146 mboe per day for second-half 2024.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BristolMyersSquibb--Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients wi
